Abstract
The impact of tricuspid regurgitation (TR) on outcomes after transcatheter mitral valve repair (TMVr) with MitraClip in heart failure (HF) pts with secondary mitral regurgitation (MR) is poorly understood. In the COAPT trial, 614 pts with HF and moderate to severe (3+) or severe (4+) symptomatic
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have